Dr. Lionel Budry

Post-Doctoral Fellowship Award 2013-2015
Université de Montréal (Montréal, QC)

Supervisor

Dr. Thierry Alquier

Dr. Budry’s research aimed to provide a better understanding of how the hypothalamus, an area of the brain, works to help detect circulating fatty acids. This research may help identify a new target that may be involved in the relationship between obesity and type 2 diabetes.

Dr. Sanjoy Ghosh

Operating Grant 2012-2015 & Scholar Award 2010-2015
University of British Columbia-Okanagan (Kelowna, BC)

Dr. Ghosh and his team investigated how omega-6 fatty acid causes damage in the mitochondria, the energy-producer of cells, and assessed if the damage can be reduced by supplementation with omega-3s. This research aimed to identify the process by which common dietary fats are increasing obesity and diabetes‐ related heart disease in Canada.

Dr. Amira Klip

Operating Grant 2012-2015
The Hospital for Sick Children (Toronto, ON)

Dr. Klip, co-investigator Dr. Warren Lee and their team investigated why white blood cells are attracted to muscle tissues during obesity and if it is possible to prevent insulin resistance by keeping these white blood cells out of these tissues. Dr. Klip hopes to better understand how inflammation happens and how it contributes to insulin resistance. She hopes to block white blood cells from entering muscles, which could prevent insulin resistance and type 2 diabetes.

Dr. Julie L. Lavoie

Operating Grant 2011-2014
Université de Montréal (Montréal, QC)

Dr. Lavoie used mouse models to investigate a promising anti-obesity drug. Her previous studies have shown that mice which develop obesity by being placed on a typical North American diet (rich in sugar and fat) gained less weight while receiving this drug. In this study, Dr. Lavoie wanted to determine if the drug could also lower other health risks, such as diabetes. A drug that could treat obesity and also reduce many of its complications, such as type 2 diabetes, would be of extreme usefulness clinically.

Dr. Gary D. Lopaschuk

Operating Grant 2012-2015
University of Alberta (Edmonton, AB)

Dr. Lopaschuk studied a molecule that regulates body fat metabolism to understand how certain hormones impact the body’s ability to control energy. This knowledge may be useful in developing new therapies that could treat obesity and, therefore, decrease the incidence of diabetes.

Dr. Jonathan D. Schertzer

Operating Grant 2012-2015
McMaster University (Hamilton, ON)

Dr. Schertzer aims to find out how a certain protein in the immune system helps protect the body against insulin resistance and if eating probiotics can help activate this protein. Results from this work may show that probiotics are an effective, inexpensive way to reduce the risk of type 2 diabetes.

Dr. Eva Tudurí

Post-Doctoral Fellowship 2011-2014
University of British Columbia (Vancouver, BC)

Supervisor

Dr. Timothy J. Kieffer

Leptin resistance in the brain has been reported in obese individuals. Dr. Tudurí’s research aimed to better understand the consequences caused by the lack of leptin signalling in the endocrine pancreas and the cellular mechanisms that underlie these consequences. This research could lead to the development of new therapies for people with type 2 diabetes.

Dr. Minna Woo

Operating Grant 2011-2014
St Michael's Hospital (Toronto, ON)

Dr. Minna Woo investigated the factors within liver cells that make the body either metabolically healthy or unhealthy, which can determine diabetes outcome. This research will enable us to better understand the relationship between fatty liver and type 2 diabetes, which could lead to new strategies for disease treatment.

For more information on previously funded research projects, please contact research@diabetes.ca.

Click here to see the currently funded CDA research on obesity.